Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Integrated effects of the vasodilating beta-blocker nebivolol on exercise performance, energy metabolism, cardiovascular and neurohormonal parameters in physically active patients with arterial hypertension

Journal of Human Hypertension volume 15, pages 715–721 (2001)Cite this article

Abstract

Objective: The present study was designed to investigate the integrated effects of the beta-1-selective blocker with vasodilator properties, nebivolol, on systemic haemodynamics, neurohormones and energy metabolism as well as oxygen uptake and exercise performance in physically active patients with moderate essential hypertension (EH).

Design and methods: Eighteen physically active patients with moderate EH were included: age: 46.9 ± 2.38 years, weight: 83.9 ± 2.81 kg, blood pressure (BP): 155.8 ± 3.90/102.5 ± 1.86 mm Hg, heart rate: 73.6 ± 2.98 min−1. After a 14-day wash-out period a bicycle spiroergometry until exhaustion (WHO) was performed followed by a 45-min submaximal exercise test on the 2.5 mmol/l lactate-level 48 h later. Before, during and directly after exercise testing blood samples were taken. An identical protocol was repeated after a 6-week treatment period with 5 mg nebivolol/day.

Results: Nebivolol treatment resulted in a significant (P < 0.01) decrease in systolic and diastolic BP and heart rate at rest and during maximal and submaximal exercise. Maximal physical work performance, blood lactate and rel. oxygen uptake (rel. VO2) before and after nebivolol treatment at rest and during maximal and submaximal exercise remained unaltered. Free fatty acid, free glycerol, plasma catecholamines, beta-endorphines and atrial natriuretic peptide (ANP) increased before and after treatment during maximal and submaximal exercise but remained unaltered by nebivolol treatment. In contrast, plasma ANP levels at rest were significantly higher in the presence of nebivolol, endothelin-1 levels were unchanged.

Conclusions: Nebivolol was effective in the control of BP at rest and during exercise in patients with EH. Furthermore, nebivolol did not negatively affect lipid and carbohydrate metabolism and substrate flow. The explanation for the effects on ANP at rest remain elusive. This pharmacodynamic profile of nebivolol is potentially suitable in physically active patients with EH.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Blair SN et alChanges in physical fitness and all-cause mortality. A prospective study of healthy and unhealthy men JAMA 1995 273 1093–1098

    Article  CAS  Google Scholar 

  2. Paffenbarger RS Jret al The association of changes in physical-activity level and other lifestyle characteristics with mortality among men N Engl J Med 1993 328 538–545

    Article  Google Scholar 

  3. Manson JE et alA prospective study of walking as compared with vigorous exercise in the prevention of coronary heart disease in women N Engl J Med 1999 341 650–658

    Article  CAS  Google Scholar 

  4. Hakim AA et alEffects of walking on mortality among nonsmoking retired men N Engl J Med 1998 338 94–99

    Article  CAS  Google Scholar 

  5. Rost R Significance of physical activity in the prevention of atherosclerotic disease Dtsch Z Sportmed 1995 46 (Suppl 1) 58–72

    Google Scholar 

  6. Pate RR et alPhysical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine JAMA 1995 273 402–407

    Article  CAS  Google Scholar 

  7. Zanchetti A et alThe 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting Blood Press 1993 2 86–100

    Article  CAS  Google Scholar 

  8. Predel HG, Rohden C, Heine O, Rost RE Influence of the nonsulfhydryl angiotensin-converting enzyme inhibitor trandolapril on lipid and carbohydrate metabolism related to exercise capacity in healthy subjects Am Heart J 1993 125 1532–1535

    Article  CAS  Google Scholar 

  9. Vanhees L, Fagard R, Lijnen P, Amery A Effect of antihypertensive medication on endurance exercise capacity in hypertensive sportsmen J Hypertens 1991 9 1063–1068

    Article  CAS  Google Scholar 

  10. Guidelines set new definitions, update treatment for hypertension Bull World Health Organ 1999 77 293

  11. Petrella RJ How effective is exercise for the treatment of hypertension Clin J Sport Med 1998 8 224–231

    Article  CAS  Google Scholar 

  12. MacMahon M, Palmer R Exercise and hypertension Med Clin North Am 1985 69 57–70

    Article  Google Scholar 

  13. Seals R, Hageberg J The effects of exercise training on human hypertension, a review Med Sci Sports Exerc 1984 16 207–215

    Article  CAS  Google Scholar 

  14. Dubbert PM et alEndurance exercise in mild hypertension: effects on blood pressure and associated metabolic and quality of life variables. Department ofVeterans Affairs Medical Centre, Jackson, MS J Hum Hypertens 1994 8 265–272

    CAS  PubMed  Google Scholar 

  15. Goldberg L, Elliot DL The effect of exercise on lipid metabolism in men and women Sports Med 1987 4 307–321

    Article  CAS  Google Scholar 

  16. Lampman RM, Schteingart DE Effects of exercise training on glucose control, lipid metabolism, and insulin sensitivity in hypertriglyceridemia and non-insulin dependent diabetes mellitus Med Sci Sports Exerc 1991 23 703–712

    Article  CAS  Google Scholar 

  17. Ferrannini E et alInsulin resistance in essential hypertension N Engl J Med 1987 317 350–357

    Article  CAS  Google Scholar 

  18. Clarkson P et alExercise training enhances endothelial function in young men J Am Coll Cardiol 1999 33 1379–1385

    Article  CAS  Google Scholar 

  19. Grassi G et alPhysical exercise in essential hypertension Chest 1992 101 (Suppl 5) 312–314

    Article  Google Scholar 

  20. Karvonen MJ Physical Activity for a Healthy Life 1996 RQRS 67 213–215

    Article  CAS  Google Scholar 

  21. Hansson L, Hedner T, Himmelmann A The 1999 WHO-ISH Guidelines for the Management of Hypertension – new targets, new treatment and a comprehensive approach to total cardiovascular risk reduction Blood Press 1999 8 (Suppl 1) 3–5

    Google Scholar 

  22. Janssens WJ Pharmacology of nebivolol J Pharm Belg 1992 47 323–327

    CAS  PubMed  Google Scholar 

  23. Van Bortel LM et alPharmacological properties of nebivolol in man Eur J Clin Pharmacol 1997 51 379–384

    Article  CAS  Google Scholar 

  24. De Cree J, Cobo C, Gaukens H, Verhaegen H Comparison of the subacute haemodynamic effects of atenolol, propranolol, pindolol and nebivolol Angiology 1990 41 95–105

    Article  CAS  Google Scholar 

  25. Paffenbarger RS Jr, Hyde RT, Wing AL, Hsieh CC Physical activity, all-cause mortality and longevity of college alumni N Engl J Med 1986 314 605–613

    Article  Google Scholar 

  26. Kaplan NM, Grffard RW Choice of initial therapy for hypertension JAMA 1996 275 1577–1580

    Article  CAS  Google Scholar 

  27. Kindermann W Antihypertensive differential therapy in physically active subjects Dtsch Z Sportmed 1998 48 299–305

    Google Scholar 

  28. Palatini P Exaggerated blood pressure response to exercise: pathophysiologic mechanism and clinical relevance J Sports Med Phys Fitness 1998 38 1–9

    CAS  PubMed  Google Scholar 

  29. De Meirleir K, Arentz T, Hollmann W, Vanhaelst L The role of endogenous opiates in thermal regulation of the body during exercise Br Med J (Clin Res Ed) 1985 290 739–740

    Article  CAS  Google Scholar 

  30. de Meirleir K et alBeta-endorphin and ACTH levels in peripheral blood during and after aerobic and anaerobic exercise Eur J Appl Physiol 1986 55 5–8

    Article  CAS  Google Scholar 

  31. Assmann G, Schulte H Relation of high density lipoprotein and triglycerides to incidence of atherosklerotic coronary artery disease (the PROGRAM experience) Am J Cardiol 1992 70 733–737

    Article  CAS  Google Scholar 

  32. Predel HG, Rhoden C, Heine O, Rost RE Influence of the nonsulfhydryl angiotensin-converting enzyme inhibitor trandolapril on lipid and carbohydrate metabolism related to exercise capacity in healthy subjects Am Heart J 1993 125 1532–1535

    Article  CAS  Google Scholar 

  33. Krone W, Müller-Wieland D Hyperlipidaemia and hypertension Baillière’s Clin Endocr Metab 1990 4 777–806

    Article  Google Scholar 

  34. Middeke M, Weisweiler P, Schwandt P, Holzgreve H Serum lipoproteins during antihypertensive therapy with beta blockers and diuretics: a controlled long-term comparable trial Clin Cardiol 1987 10 94–98

    Article  CAS  Google Scholar 

  35. Middeke M et alNormalisation of lipid metabolism after withdrawal of antihypertensive long-term therapy with beta-blockers and diuretics Arteriosclerosis 1990 10 145–147

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Cardiology and Sports Medicine, German Sports University, Cologne, Germany

    HG Predel, W Mainka, W Schillings, H Knigge, J Montiel, T Schramm, C Graf, B Bjarnason-Wehrens, U Prinz & RE Rost

  2. Berlin-Chemie AG, Glienicker Weg 125, Berlin, D-12489, Germany

    Jv. Fallois & R Agrawal

  3. CRM GmbH, Weiherstrasse 19, Rheinbach, D-53359, Germany

    BM Giannetti

Authors
  1. HG Predel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W Mainka
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. W Schillings
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H Knigge
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J Montiel
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jv. Fallois
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. R Agrawal
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. T Schramm
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. C Graf
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. BM Giannetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. B Bjarnason-Wehrens
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. U Prinz
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. RE Rost
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to HG Predel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Predel, H., Mainka, W., Schillings, W. et al. Integrated effects of the vasodilating beta-blocker nebivolol on exercise performance, energy metabolism, cardiovascular and neurohormonal parameters in physically active patients with arterial hypertension. J Hum Hypertens 15, 715–721 (2001). https://doi.org/10.1038/sj.jhh.1001257

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001257

Keywords

This article is cited by

Search

Advanced search

Quick links